The aim of this project is to gain deeper understanding of the direct effects of CKD on cardiomyocyte function, by investigating the effect of uremic toxins on cardiomyocytes, both in vitro and in vivo.  
My project will reveal novel mediators negatively affecting cardiomyocyte function in CKD, enabling novel strategies to reduce cardiovascular risk in CKD patients.